Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.

Sustainability and MDR: The Catalysts Sparking Change in Market Development and Innovation

Device regulations are imperative for the quality and safety of medical care by ensuring patients are not exposed to harmful products. As such, medical regulatory bodies are focused on mitigating the risk of patient harm and ensuring the safety of devices used in treatment. In May 2021, the Medical Device Regulation (MDR) came into force leading to subsequent impacts on the legislative requirements of medical devices sold to the European Union.

Clinical Data: How to Monetisation for Real-World Use

23rd November – In this insight, we discuss the BioTechX conference in Basel and what the conference’s discourse revealed about cRWD and it’s potential over the next few years.

Signify Premium Insight: Amazon in Prime Position with HealthLake Plans

Signify Premium Insights Subscription Required

22nd November 2022 – Amazon, like several of its Big Tech peers, has redoubled its efforts in medical imaging. The Seattle-based firm makes some bold claims, but will they be enough to win custom away from its rivals?

Signify Premium Insight: Calm Before the German Hospital EHR Storm

Signify Premium Insights Subscription Required

22nd November 2022 – EHR vendors are yet to feel the full impact of Germany’s €4.3B hospital digitalisation project. But it is only a matter of time before they do. 

Signify Premium Insight: GE Dreams Big with HealthCare IPO

Signify Premium Insights Subscription Required

17th November 2022 – In preparation for its IPO in January, GE HealthCare has released its Form 10 filing, which lays out the business’s priorities for its life as an independent vendor. There is ample opportunity before it, but how can GE best capitalise?